Видео с ютуба Fred Lublin

Hope for Progressive MS 2012 by Fred Lublin, MD

A Labeling Indication of SPMS Can Treat More Patients

Defining active Secondary Progressive Multiple Sclerosis

MyCounterpane One On One With Dr. Fred Lublin

Fred Lublin, MD: Current Challenges in MS

Treating the Whole Disease - National MS Society

Fred Lublin, MD: Biomarkers in MS

Fred Lublin, MD: The Primary Care Partnership in Multiple Sclerosis

Determining SPMS as Biological Instead of Classification

Fred Lublin, MD: Beginning to Treat Progressive Multiple Sclerosis

The challenge of treating progressive MS - Fred Lublin, MD - Medpage Today

Fred Lublin, MD, Examines Research and Key Takeaways from ECTRIMS 2013

Multiple Sclerosis - Fred D. Lublin, MD

Fred Lublin, MD, discusses the vital information that’s needed to optimally characterize MS

Secondary Progressive Multiple Sclerosis: Managed Care Implications

How Long Do I Stay on Therapy? - National MS Society

Dr. Fred D. Lublin Invites You to the 3rd Annual International Congress on the Future of Neurology®

Clinical Features of Secondary Progressive Multiple Sclerosis

Questions and Answers with Dr. Fred Lublin at ACTRIMS 2016

Is My Disease Modifying Therapy Working? - National MS Society